Evolent Health
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.86 | -100% | -52.22 | -100% |
| P/S |
|
1.82 | 4.06 | -55.28% |
|
|
| P/BV |
|
3.34 | 9.39 | -64.41% |
|
|
| P/FCF |
|
26.27 | 46.57 | -43.6% |
|
|
| Ev/Ebitda |
|
86.69 | 17.55 | 393.96% |
|
|
| Ev/S |
|
2.05 | 4.36 | -53% |
|
|
| Ev/FCF |
|
35.32 | 54.43 | -35.1% |
|
|
| E/P |
|
-0.0378 | 0.2164 | -117.47% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
1/10
|
2.36 | 20.15 | -88.28% | 1.3 | +81.85% |
| ROE |
|
-10.59 | -80.86 | -86.91% |
|
|
| ROA |
|
-4.22 | 6.71 | -162.81% |
|
|
| ROIC |
|
-2.2 | 15.68 | -114.03% |
|
|
| ROS |
|
-5.76 | 10.56 | -154.57% |
|
|
| ROCE |
|
-7.21 | 18.05 | -139.97% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
13.08 | 2.82 | 364.61% | 2.83 | +362.61% |
| Nеt Debt/Ebitda |
|
9.74 | 3.64 | 167.94% |
|
|
| Debt/Ratio |
|
0.2264 | 0.261 | -13.26% |
|
|
| Debt/Equity |
|
6.9 | 4.81 | 43.62% |
|
|
| Debt/Net Income |
|
-5.37 | 6.35 | -184.56% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.29 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.33 | -100% | ||
| DSI |
|
0 | 0.7376 | -100% |
|
|
| Average dividend growth |
|
0 | -3.12 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.29 | -100% |
|
|
| Average percentage for payments |
|
16.63 | 77.61 | -78.58% |
|
|
| Difference from average difference in sector |
|
-1.29 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
132.03 | 362.86 | -63.61% | ||
| Growth impulse Ebitda in 5 years |
|
-62.16 | 373.75 | -116.63% | ||
| Growth impulse Net Income in 5 years |
|
-63.01 | 454.84 | -113.85% | ||
| Growth impulse FCF in 5 years |
|
-245.57 | 306.17 | -180.21% | ||
| Growth impulse EPS in 5 years |
|
-72.61 | 455.99 | -115.92% |
IP Score
2.14/10
